Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
International Immunopharmacology|November 22, 2011
Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase/AKT and NF-E2-related factor-2 signaling pathway in astrocytesJia-Hong Chen, Ssu-Ming Huang, Tzu-Wei Tan, et al.Science (New York, N.Y.)|November 4, 2021
Rapid assessment of SARS-CoV-2-evolved variants using virus-like particlesAbdullah M Syed, Taha Y Taha, Takako Tabata, et al.European Journal of Medicinal Chemistry|July 25, 2021
Design and synthesis of novel orally selective and type II pan-TRK inhibitors to overcome mutations by property-driven optimizationMu-Chun Li, Wen-Hsing Lin, Pei-Chen Wang, et al.Cell|November 28, 2021
Identification of a therapeutic interfering particle-A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistanceSonali Chaturvedi, Gustavo Vasen, Michael Pablo, et al.Journal of Pharmaceutical and Biomedical Analysis|July 26, 2022
Carboxylated fluorescent microsphere based immunochromatographic test strip enabled sensitive and quantitative on-site detection for florfenicol in eggsCheng Peng, Jun-Fa Liang, Lin-Feng Jiang, et al.European Journal of Medicinal Chemistry|April 16, 2018
Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibitionYi-Yu Ke, Chun-Ping Chang, Wen-Hsing Lin, et al.Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particlesAbdullah M Syed, Alison Ciling, Mir M Khalid, et al.Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particlesAbdullah M Syed, Alison Ciling, Taha Y Taha, et al.Science Translational Medicine|March 16, 2021
SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19Juan A Perez-Bermejo, Serah Kang, Sarah J Rockwood, et al.Bioorganic Chemistry|March 16, 2020
Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitorsShu-Yu Lin, Chun-Feng Chang, Mohane Selvaraj Coumar, et al.Pageof 9